Hims & Hers is now offering generic semaglutide through its platform to eligible customers in Canada, marking the company’s first international generic GLP-1 offering. The personalized treatment plans, which include medication access plus ongoing care support and lifestyle guidance, start at $149 CAD per month, significantly below the typical cost of branded versions like Ozempic. Generic semaglutide is authorized by Health Canada for Type 2 diabetes and may be prescribed off‑label for weight management by licensed Canadian providers. Hims & Hers does not currently offer treatment services for Type 2 diabetes in Canada and instead focuses on weight‑management programs delivered through its telehealth platform with local Canadian medical providers. Sources: Hims & Hers Expands GLP-1 Offering in Canada with Generic ... Generic Semaglutide Coming to Canada 2026 | Get Notified - Hers HIMS Launches Generic Semaglutide in Canada Hims & Hers Introduces Access to Gene...
- Get link
- X
- Other Apps